DEBORAH GIORGI-GUARNIERI: Open Payments
NPI 1710960034 · WILLIAMSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 37 payments from 9 companies in 2025. Trend: 2023 $528 · 2024 $757 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $523 |
| Axsome Therapeutics, Inc. | 6 | $119 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| Lundbeck LLC | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| HARMONY BIOSCIENCES LLC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
Products named: COBENFY, REXULTI, Auvelity, TRINTELLIX, INGREZZA, WAKIX, ABILIFY MAINTENA, CAPLYTA.
Industry payments across VA — which companies pay providers there.
